Mbikay Majambu
Chronic Disease Program, Ottawa Hospital Research Institute Ottawa, ON, Canada.
Front Pharmacol. 2012 Mar 1;3:24. doi: 10.3389/fphar.2012.00024. eCollection 2012.
Moringa oleifera (M. oleifera) is an angiosperm plant, native of the Indian subcontinent, where its various parts have been utilized throughout history as food and medicine. It is now cultivated in all tropical and sub-tropical regions of the world. The nutritional, prophylactic, and therapeutic virtues of this plant are being extolled on the Internet. Dietary consumption of its part is therein promoted as a strategy of personal health preservation and self-medication in various diseases. The enthusiasm for the health benefits of M. oleifera is in dire contrast with the scarcity of strong experimental and clinical evidence supporting them. Fortunately, the chasm is slowly being filled. In this article, I review current scientific data on the corrective potential of M. oleifera leaves in chronic hyperglycemia and dyslipidemia, as symptoms of diabetes and cardiovascular disease (CVD) risk. Reported studies in experimental animals and humans, although limited in number and variable in design, seem concordant in their support for this potential. However, before M. oleifera leaf formulations can be recommended as medication in the prevention or treatment of diabetes and CVD, it is necessary that the scientific basis of their efficacy, the therapeutic modalities of their administration and their possible side effects be more rigorously determined.
辣木（Moringa oleifera）是一种被子植物，原产于印度次大陆，其各个部位在历史上一直被用作食物和药物。现在它在世界所有热带和亚热带地区都有种植。这种植物的营养、预防和治疗功效在互联网上备受赞誉。食用其部分被宣传为一种个人健康维护和自我治疗各种疾病的策略。人们对辣木健康益处的热情与支持这些益处的有力实验和临床证据的稀缺形成了鲜明对比。幸运的是，这一差距正在慢慢被填补。在本文中，我回顾了关于辣木叶子对慢性高血糖和血脂异常（糖尿病和心血管疾病风险的症状）纠正潜力的当前科学数据。在实验动物和人类中报道的研究虽然数量有限且设计各异，但在支持这种潜力方面似乎是一致的。然而，在辣木叶制剂可被推荐用于预防或治疗糖尿病和心血管疾病之前，有必要更严格地确定其功效的科学依据、给药的治疗方式及其可能的副作用。
